Angela DeMichele, MD @AngieDemichele @PennMedicine @UofPenn @PennCancer #SABCS21 #PALLAS #BreastCancer #Research Phase III PALLAS Trial

Angela DeMichele, MD, MSCE, Co-Leader, Breast Cancer Research Program, Director, Breast Cancer Clinical Trials Unit, Co-Director, 2-PREVENT Breast Cancer Translational Center of Excellence, Alan and Jill Miller Professor in Breast Cancer Excellence from Penn Medicine and PennMedicine’s Abramson Cancer Center. In this video, she speaks about the SABCS 2021 Abstract – GS1-07 Adjuvant palbociclib in HR+/HER2- early breast cancer: Final results from 5,760 patients in the randomized phase III PALLAS trial.